Please login to the form below

Not currently logged in
Email:
Password:

Kathryn Gallant leaves Hall & Partners to join Insight Health US

Appointed joint CEO alongside Jessica Cunningham

Kathryn Gallan, Insight Health USConsultancy firm Insight Health US has appointed former managing partner at Hall & Partners Kathryn Gallant as joint CEO.

Gallant joins fellow CEO Jessica Cunningham at the New York-based firm, where she replaces Avanti Ananthram who is due to move to the UK to become head of international development at parent company Insight Research Group.

Gallant's duties will include driving the growth of Insight Health US.

In total, Gallant has 14 years' experience in market research spanning both global and US domestic healthcare research, eight of which have been at Hall & Partners.

Prior to this, she was a director at Strategic Marketing Corporation.

Jane Shirley, CEO of Insight Research Group, said: “We are delighted that Kathryn will be joining us to help drive the next stage of Insight's growth in the US. Kathryn has a great reputation within the industry that fits perfectly with Insight's focus on delivering top quality, truly insightful research.”

15th January 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics